Active Esophageal Variceal Bleeding Treated with Band Ligation

1999 ◽  
Vol 17 (3) ◽  
pp. 180-180
Author(s):  
Richard S. Bloomfeld ◽  
Scott R. Brazer
Keyword(s):  
Variceal Bleeding ◽  
Esophageal Variceal ◽  
Esophageal Variceal Bleeding ◽  
Band Ligation

scholarly journals Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection-Therapy: A Retrospective Study

PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0126525 ◽  
Author(s):  
Martin Müller ◽  
Thomas Seufferlein ◽  
Lukas Perkhofer ◽  
Martin Wagner ◽  
Alexander Kleger
Keyword(s):  
Retrospective Study ◽  
Variceal Bleeding ◽  
Injection Therapy ◽  
Metal Stents ◽  
Esophageal Variceal ◽  
Esophageal Variceal Bleeding ◽  
Band Ligation

scholarly journals Comparative Efficacy of Terlipressin and Octreotide along with Endoscopic Band Ligation in the Management of Esophageal Variceal Bleeding

2021 ◽  
Vol 2 (2) ◽  
pp. 41-48
Author(s):  
Sadia Asif ◽  
Ayesha Shehbaz Khan ◽  
Sarmad Zahoor ◽  
Hafiz Mudabbar Mahboob ◽  
Uzma Malik ◽  
...  
Keyword(s):  
Variceal Bleeding ◽  
Medical Emergency ◽  
Esophageal Variceal ◽  
Esophageal Variceal Bleeding ◽  
Band Ligation ◽  
Female Patients ◽  
Group A ◽  
Cirrhotic Patients ◽  
Endoscopic Band Ligation ◽  
Group B

Esophageal variceal bleeding is a medical emergency that carries a high mortality rate despite appropriate management. Terlipressin and Octreotide are two common agents used as adjuvant agents in the management of variceal bleeding. The objective of this study is to compare the effectiveness of Terlipressin with Octreotide along with endoscopic band ligation in the management of esophageal variceal bleeding in cirrhotic patients. This randomized control study was carried out at the Department of General Medicine, Fatima Memorial Hospital, Lahore, for six months extending from February 2019 to July 2019. A total of 100 cirrhotic patients were selected /based on predetermined inclusion and exclusion criteria. The patients were randomly divided into two groups of equal strength. Hence, 50 patients were included in Group A and 50 patients were included in Group B along with banding. Group A received Terlipressin whereas Group B received Octreotide. The two groups were monitored for variceal bleeding for 72 hours. The mean age of the patients in Group A was 55.9±7.3 years and for the patients in Group B it was 56.8±7.4 years. In Group A, 36 (72.0%) male and 14 (28.0%) female patients were included. In Group B, there were 34 (68.0%) male and 16 (32.0%) female patients. In Group A, the treatment was effective for 46 (92.0%) patients and in Group B, 36 (72.0%) patients had an effective treatment. It is concluded from this study that Terlipressin is statistically more effective than Octerotide in terms of preventing esophageal variceal bleeding.

S1834 Esophageal Variceal Band Ligation (EVL) Plus Beta-Blocker (BB) Treatment in the Primary Prophylaxis of Esophageal Variceal Bleeding

2009 ◽  
Vol 136 (5) ◽  
pp. A-826
Author(s):  
Lance L. Stein ◽  
Sameer M. Mazhar ◽  
Charles Gabbert ◽  
Tarek Hassanein ◽  
David Kravetz
Keyword(s):  
Beta Blocker ◽  
Variceal Bleeding ◽  
Primary Prophylaxis ◽  
Esophageal Variceal ◽  
Esophageal Variceal Bleeding ◽  
Band Ligation
Sign in / Sign up

Export Citation Format

Share Document